Ani Pharmaceuticals (ANIP) Stock

NASDAQ / Healthcare / Drug Manufacturers - Specialty & Generic

$71.25

+5.10% Close Nov 10

ANIP stock is in a downtrend, sits in Stage 1 basing, and does not meet the Minervini Trend Template.

ANIP stock daily candlestick chart with 50, 150 and 200-day moving averagesOpen interactive chart
One year of daily prices through the Nov 10, 2026 close. This page updates by about 4 AM ET after each trading day. The interactive chart has the full history.

ANIP stock price and performance

ANIP stock trades on NASDAQ and is classified in the Healthcare sector, in the Drug Manufacturers - Specialty & Generic industry. The live price table and chart on this page show current quotes, returns and moving-average lines. Readers can use them to follow how the price moves session by session. This page describes the trend state and the rules behind it.

Last close
$71.25
Day range
$67.53 to $71.36
52-week range
$67.14 to $90.87
From 52-week high
−21.6%
Average volume (50 days)
415,097
1 week
−1.4%
1 month
−3.2%
3 months
−5.2%
Year to date
−9.7%
1 year
−21.2%
3 years
+8.9%
5 years
+25.3%

Is ANIP stock in an uptrend?

No, ANIP stock is in a downtrend: it does not meet the Minervini Trend Template criteria and neither Daily Pivot Breakout momentum filter is active. Price is below its 200-day moving average.

ANIP stock is in a downtrend by the trend rules on this page. It does not meet the Minervini Trend Template. The Daily Pivot Breakout momentum filters measure the 100-day rate of change and the 100-day EMA slope, each compared with a minimum. The Weinstein stage is Stage 1 (basing), a phase that uses the 30-week moving average and Mansfield relative strength to show whether a stock is building a base.

Daily Pivot momentum filters
0 of 2 active
100-day ROC
−10.4% filter at 40%: off
100-day EMA slope
−6.3% filter at 25%: off
Trend state
Downtrend
Minervini Trend Template
Not met on the latest scan
50-day average
Below
150-day average
Below
200-day average
Below
200-day slope (1 month)
−1.39%
ATR (14) % of price
3.64%

Momentum filters from the Daily Pivot Breakout indicator: 100-day rate of change and 100-day EMA slope, each against its minimum.

Is ANIP stock in a Stage 2 uptrend?

Not yet. ANIP stock is in Stage 1 (basing) by our Weinstein stage analysis: its 30-week moving average has flattened after a decline.

Weinstein stage
Stage 1 (basing)
30-week SMA
$76.91
30-week slope (4 weeks)
−0.99%
Mansfield RS vs SPY
-12.12

Weinstein stage analysis uses weekly closes against the 30-week moving average and Mansfield relative strength versus SPY. See the free Stage 2 stocks screener.

ANIP support and resistance levels

ANIP stock has pivot high, pivot low and moving-average lines shown in the levels table. The table lists the distance between the current price and each line, so readers can compare them directly. Support and resistance readings come from these reference lines.

LevelPriceFrom close
150-day SMA$77.31+8.5%
200-day SMA$77.15+8.3%
30-week SMA$76.91+7.9%
Daily Pivot resistance (pivot high)$74.15+4.1%
50-day SMA$72.38+1.6%
21-day EMA$71.27+0.0%
9-day EMA$70.33−1.3%
Latest Daily Pivot low$69.90−1.9%

Levels above the close act as resistance, levels below as support. Last close $71.25.

ANIP breakout and scanner signals

The page tracks the VCP, RSI Divergence, Weinstein Stage Analysis, Daily Pivot Breakout, Minervini Trend Template, Episodic Pivot, Ichimoku TK cross, 9/21 EMA cross, Golden / Death Cross and RS Rating scanners. The signal table lists the dates and directions of signals from these scanners for ANIP stock. Each scanner looks for a different pattern, from trend alignment to momentum and crossover events.

ScannerLast signal (free view, 5 sessions late)Past year
VCPNone in the last year0
RSI DivergenceOct 21, 20261
Weinstein Stage AnalysisJan 22, 202638
Daily Pivot BreakoutOct 17, 20250
Minervini Trend TemplateJan 16, 20264
Episodic PivotNone in the last year0
Ichimoku TK crossOct 6, 2026 (bearish)11
9/21 EMA crossSep 30, 2026 (bearish)8
Golden / Death CrossAug 27, 2026 (bearish)3
RS RatingNone in the last year0

ANIP seasonality by month

ANIP stock has historically been strongest in April and weakest in December. These monthly patterns come from past price behavior and do not predict future results. Readers can compare them with the trend state and the live price table on this page.

  1. Jan+6.2%69% up
  2. Feb+1.1%42% up
  3. Mar−2.1%42% up
  4. Apr+13.2%58% up
  5. May−2.5%42% up
  6. Jun+3.9%67% up
  7. Jul−3.7%41% up
  8. Aug+0.4%41% up
  9. Sep+2.1%41% up
  10. Oct−3.4%44% up
  11. Nov+7.9%58% up
  12. Dec−5.3%42% up

Average monthly return over 26+ years of stored daily closes, and the share of years each month closed higher.

ANIP earnings history

ANIP stock last reported quarterly earnings on Nov 5, 2026. Results came in above the estimate. The earnings result is one of the inputs in the bullish and bearish factors on this page.

ReportedEPS estimateEPS actualSurprise
Nov 5, 2026$2.18$2.70+23.9%
Aug 7, 2026$2.04$2.21+8.3%
Jun 25, 2026$-0.14$-0.16−14.3%
May 8, 2026$1.30$2.05+57.7%

ANIP bull and bear case

Bullish factors for ANIP stock include the Stage 1 (basing) reading, which points to a base that may be forming, and the last reported quarter's results, which came in above the estimate. Bearish factors include the current downtrend state and the failure to meet the Minervini Trend Template.

What looks strong

  • No strong points in the trend data on the latest scan.

What looks weak

  • Neither Daily Pivot momentum filter is active (100-day ROC -10.4%, 100-day EMA slope -6.3%; the filters need 40% and 25%).
  • Does not meet the Minervini Trend Template on the latest scan.
  • Price is below the 200-day moving average, which is falling.
  • Short interest is 18.41% of shares outstanding.

Drawn only from the data on this page. Not a recommendation.

ANIP news and SEC filings, last 30 days

The filings table lists SEC filings for ANI Pharmaceuticals, Inc. and updates with new filings as they are added. Readers can review the form types and dates listed there. The table is the live source for the company's filing history.

Source: SEC EDGAR.

ANIP insider trading and risks

The insider table lists insider trades reported for ANIP stock, including the type of transaction and the date. Readers can check the table to see whether insiders have been buying or selling. The table updates as new insider reports are filed.

Buys, last 90 days
0 ($0)
Sales, last 90 days
4 ($840,731)
Buys, last 12 months
0 ($0)
Sales, last 12 months
4 ($840,731)
DateInsiderTradeValue
Oct 15Lalwani NikhilDirector, PRESIDENT & CEOSale 5,400 shares$388,206
Sep 29CAREY STEPHEN P.SVP & CFOSale 2,850 shares$208,050
Oct 29CAREY STEPHEN P.SVP & CFOSale 2,850 shares$207,680
Oct 13Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Sale 500 shares$36,795

Risk flags from the data

  • Short interest is 18.41% of shares outstanding.

Insider trades: SEC Form 4 open-market purchases and sales.

ANIP valuation and fundamentals

The valuation table shows the valuation measures available for ANIP stock. Readers can use the table to compare the stock's valuation figures over time. The measures are listed live on this page and are not summarized here.

Market cap
$1.55B
Enterprise value
$1.78B
P/E (trailing)
15.1
P/E (forward)
6.9
PEG
0.08
Price to sales
1.63
Price to book
2.50
EV to EBITDA
8.5
Gross margin
+62.4%
Operating margin
+15.0%
Profit margin
+11.1%
Return on equity
+20.5%
Revenue (TTM)
$978.4M
Revenue growth (quarter, y/y)
+25.9%
Cash
$377.0M
Debt
$626.0M
Beta
0.47
Fiscal yearRevenueNet incomeFree cash flow
2025$883.4M$78.3M$185.2M
2024$614.4M−$18.5M$36.3M
2023$486.8M$18.8M$86.6M
2022$316.4M−$47.9M−$45.8M

ANIP dividends and splits

ANIP stock does not pay a dividend. The dividend table on this page lists dividend dates and amounts when payments are recorded. Readers who need income from ANIP stock will not find a payment history here.

Dividend yield
0.00%
Payout ratio
0.0%

Stock splits: 1-for-6 split on Jul 18, 2013, 1-for-6 split on Jun 4, 2012, 1-for-10 split on Jun 3, 2002.

Who owns ANIP?

Shares outstanding
23.0M
Float
19.7M
Held by insiders
+5.4%
Held by institutions
+107.7%
Short interest (% of shares)
+18.4%
Days to cover
8.2

What does Ani Pharmaceuticals, Inc. do?

ANI Pharmaceuticals, Inc. is a biopharmaceutical company that develops, manufactures and commercializes branded, generic and specialty prescription medicines. Its three focus areas are Rare Disease, Generics and Established Brands. The portfolio spans ophthalmology, rheumatology, nephrology, neurology and pulmonology. The company also offers contract manufacturing and pharmaceutical development services using U.S.-based facilities.

CEO
Mr. Nikhil Lalwani
Employees
970
Headquarters
Baudette, MN, United States

ANIP stock FAQ

Is ANIP stock in an uptrend?

No, ANIP stock is in a downtrend: it does not meet the Minervini Trend Template criteria and neither Daily Pivot Breakout momentum filter is active. Price is below its 200-day moving average.

Is ANIP stock in a Stage 2 uptrend?

Not yet. ANIP stock is in Stage 1 (basing) by our Weinstein stage analysis: its 30-week moving average has flattened after a decline.

Does ANIP stock meet the Minervini Trend Template?

ANIP stock does not meet the Minervini Trend Template by the rules on this page. The Template checks the stacking order of the 50-day, 150-day and 200-day moving averages and the stock's position in its yearly range. The trend section lists these checks in full.

What are ANIP stock's support and resistance levels?

ANIP stock's support and resistance levels are shown in the levels table through pivot highs, pivot lows and moving-average lines. The table lists the distance from the current price to each line.

When did ANIP last report earnings?

ANIP stock last reported quarterly earnings on Nov 5, 2026. Results came in above the estimate. The earnings section on this page gives the same date and result.

Are insiders buying or selling ANIP stock?

The insider table on this page lists insider trades for ANIP stock, with transaction types and dates. The table updates as new insider reports are filed.

What is ANIP stock's best and worst month historically?

ANIP stock has historically been strongest in April and weakest in December. These patterns come from past price behavior and do not predict future results. The seasonality section on this page covers the same months.

Does ANIP stock pay a dividend?

ANIP stock does not pay a dividend. The dividend table lists dividend dates and amounts when payments are recorded. Readers can check that table for any payment history.

What are the main bullish and bearish factors for ANIP stock?

Bearish factors include the downtrend state and the failure to meet the Minervini Trend Template. The bullbear section lists these factors in full.

What does ANI Pharmaceuticals do?

ANI Pharmaceuticals, Inc. develops, manufactures and commercializes branded, generic and specialty prescription medicines. It focuses on Rare Disease, Generics and Established Brands. The company also provides contract manufacturing and pharmaceutical development services.

What sector and industry is ANIP stock in?

ANIP stock is in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry on NASDAQ. The price section on this page gives the same classification. The live price table and chart show the current market data.

Updated Nov 10, 2026. Prices and fundamentals: Source: Twelve Data. Filings and insider trades: SEC EDGAR. Charts: TradingView Lightweight Charts. Educational information, not investment advice.